Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1David A. Barbie, William C. Hahn, Anna C. Schinzel et al.|Nature|2009Cited by 4.2k
Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1Yuxiong Feng, Piyush B. Gupta|Nature Communications|2017Cited by 138
De-Differentiation Confers Multidrug Resistance Via Noncanonical PERK-Nrf2 SignalingCatherine Del Vecchio Fitz, Piyush B. Gupta|PLoS Biology|2014Cited by 114